Condition
Ependymoma Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Ependymoma Recurrent clinical trials that are recruiting, at sites in 8 countries (most in United States (3), Spain (2), Austria (1)). By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 8Countries
Newest Ependymoma Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Neuro-navigation-guided focused ultrasound with nivolumab for relapsed or progressive high-grade brain tumors in children | Phase 1 | Washington D.C., District of Columbia | Recruiting | Jun 24, 2026 |
| TP53 gene therapy (SGT-53) with nivolumab and focused radiation for children with recurrent brain tumors | Early Phase 1 | Washington D.C., District of Columbia | Recruiting | Jun 12, 2025 |
| Combining Lutathera® and Olaparib for treating recurrent solid tumors in children and adolescents | Phase 1/2 | Boadilla del Monte, Madrid | Recruiting | Sep 23, 2024 |
| New treatment for children with recurrent brain tumors | Phase 2 | Chicago, Illinois and 21 other locations | Recruiting | May 19, 2011 |
All recruiting trials (4)
-
Neuro-navigation-guided focused ultrasound with nivolumab for relapsed or progressive high-grade brain tumors in children
This study tests whether using focused ultrasound to open the blood-brain barrier and give nivolumab is safe and feasible for kids with relapsed or progressive DMG/DIPG or other high-grade brain tumors.
-
TP53 gene therapy (SGT-53) with nivolumab and focused radiation for children with recurrent brain tumors
This study tests a TP53 gene therapy called SGT-53 combined with the immune drug nivolumab and focused radiation in children whose brain tumors have come back, grown, or not responded to prior treatment.
-
Combining Lutathera® and Olaparib for treating recurrent solid tumors in children and adolescents
This study is testing if combining Lutathera® with olaparib can help children and teenagers with hard-to-treat solid tumors that have certain receptors.
-
New treatment for children with recurrent brain tumors
This study is testing a new treatment combining an intravenous drug with five oral medications to see if it can help children with recurring brain tumors live longer and feel better.
Related topics
Quick answers
How many Ependymoma Recurrent clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), Spain (2 trials), Austria (1 trial), Czechia (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.